法国图卢兹消息:直至最近内分泌学家还在专心考虑怎样最有效地利用数量有限的人生长激素(HGH)。如今HGH已可大量生产(尽管昂贵),但怎样最佳利用HGH仍在继续争论。在这里召开的欧洲儿科内分泌学会议上,重新提出的议题是怎样最有效地治疗矮小病人和其他哪些人可从治疗中获益。内分泌学家正在试验以HGH治疗患Turner氏综合征的矮小女孩。他们也在对尽管不缺乏HGH但身高低于其年龄和发育缓慢的儿童作类似的 Toulouse, France: Until recently, endocrinologists were still contemplating how best to utilize a limited number of human growth hormone (HGH). HGH is now mass-produced (albeit expensive), but how to make the best use of HGH continues to argue. At the European Pediatric Endocrinology Conference here, the re-proposed topic is how to treat the shortest and other people the most effective way to benefit from treatment. Endocrinologists are experimenting with HGH to treat the little girl with Turner’s syndrome. They are also similar to children who do not lack HGH but are younger than their age and are slow to develop